Similar Posts
Strategies for Optimal Scale-up and Technology Transfer
Introduction Overcoming drug development challenges requires a science-driven approach enhanced by data-driven decision-making and working with the right contract development and manufacturing…
Regulatory Support: Secure Your IP & Navigate Clinical Trials
Our regulatory team completes over 150 agency submissions each year, supporting all stages of the product lifecycle. We assign a dedicated regulatory…
Mapping the Pathway to Designing Successful Treatments
Efficient, comprehensive transitions from early phase (preclinical up to phase 1) to late phase (phase 2 and beyond) are critical to the…
Pharma Prime™- Seamless Transition from Clinic to Market
Renejix’s Prime Pharma Solution offers the fastest route from clinical to commercial manufacturing. Through a proactive strategy, it evaluates production aspects in…
CDMO vs CMO and CRO | What is the difference?
Companies often rely on external partners to help bring their products to market efficiently and effectively. Among these partners are Contract Development…
Development of a Multi-API (Multiparticulate) Fixed-Dose Combination Drug
Abstract: This case study provides a deep dive into Renejix’s achievement in developing a multi-API (Active Pharmaceutical Ingredient) fixed-dose combination oral drug,…